Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

ETOPOSIDE

Package(a):
VIALS: 1 x 100 mg/5 ml.
Dosage(a):
See literature.
Prescribing Restrictions:    

Package(b):
VIALS: 1 x 200 mg/10 ml.
Dosage(b):
See literature.
Prescribing Restrictions:  None


Indications:
Refract. testicular tumors, small cell lung cancer, Hodgkin’s disease, malignant (non-Hodgkin’s) lymphomia (especially histocytic type), acute non-lymph. leukemia.
Contra-Indications:
Hypersensitivity to components. See prescribing information for full details.
Special Precautions:
Observe frequently for possible myelosuppression both during and after therapy. The occurrence of a platelet count below 50,000/mm3 or an absolute neutrophil count below 500/mm3 is an indication to withhold further therapy. Anaphylactic reaction. Administer by slow intravenous infusion only. Pregnancy and lactation. See prescribing information for full details.
Side Effects:
Myelosuppression, nausea and vomiting, transient hypotension, anaphylactic-like reactions, reversible alopecia. See prescribing information for full details.
Drug Interactions:
See prescribing information for full details.